To access this element change to forms mode OFF
Grant Award View - GA67188
Developing targeted antimalarial drug leads from host defence...
GA ID:
GA67188
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
20-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$1,063,037.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Developing targeted antimalarial drug leads from host defence peptide-drug conjugates
Purpose:
Malaria kills half a million people every year. Resistance to current antimalarial drugs is increasing and new types of drugs are urgently needed. We will develop a new class of drug by attaching developmental drug-like molecules to a selective peptide vehicle. The drug cargo will be delivered exclusively to infected cells to kill malaria parasites, leaving healthy cells unharmed. Our approach will improve activity and safety profiles to expand the range of drugs suited for clinical development.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1183927
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Australian National University
Recipient ABN:
52 234 063 906
Grant Recipient Location
Suburb:
Canberra City
Town/City:
Canberra City
Postcode:
2601
State/Territory:
ACT
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, QLD
Postcode:
Multiple
Country:
AUSTRALIA